FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 101 through 150 of 289

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
DYAI Nasdaq Dyadic International, Inc. 2830
EBS New York Emergent BioSolutions Inc. 2830
EDSA Nasdaq Edesa Biotech, Inc. 2830
ESAIY Over the counter Eisai Co., Ltd. 2830
ESLA Nasdaq Estrella Immunopharma, Inc. 2830
ETON Nasdaq Eton Pharmaceuticals, Inc. 2830
EVAX Nasdaq Evaxion A/S 2830
EVO Nasdaq Evotec SE 2830
EWTX Nasdaq Edgewise Therapeutics, Inc. 2830
EXEL Nasdaq Exelixis, Inc. 2830
FBLG Nasdaq FibroBiologics, Inc. 2830
FULC Nasdaq Fulcrum Therapeutics, Inc. 2830
GDTC Nasdaq CytoMed Therapeutics Limited 2830
GELS Nasdaq Gelteq Limited 2830
GKOS New York Glaukos Corporation 2830
GLMD Nasdaq Galmed Pharmaceuticals Ltd. 2830
GLUE Nasdaq Monte Rosa Therapeutics, Inc. 2830
GMAB Nasdaq Genmab A/S 2830
GNLX Nasdaq Genelux Corporation 2830
GOVX Nasdaq GeoVax Labs, Inc. 2830
GPCR Nasdaq Structure Therapeutics Inc. 2830
GRCE Nasdaq Grace Therapeutics, Inc. 2830
GSK New York GSK plc 2830
GTBP Nasdaq GT Biopharma, Inc. 2830
HCM Nasdaq HUTCHMED (China) Limited 2830
HKMPY Over the counter Hikma Pharmaceuticals PLC 2830
HRMY Nasdaq Harmony Biosciences Holdings, Inc. 2830
IBO NYSE American Impact BioMedical Inc. 2830
ICCC Nasdaq ImmuCell Corporation 2830
ICLR Nasdaq ICON Public Limited Company 2830
IMA Nasdaq ImageneBio, Inc. 2830
IMCC Nasdaq IM Cannabis Corp. 2830
IMMP Nasdaq Immutep Limited 2830
IMNM Nasdaq Immunome, Inc. 2830
IMRX Nasdaq Immuneering Corporation 2830
INAB Nasdaq IN8bio, Inc. 2830
INBX Nasdaq Inhibrx Biosciences, Inc. 2830
INCR Nasdaq InterCure Ltd. 2830
INDV Nasdaq Indivior Pharmaceuticals, Inc. 2830
INMB Nasdaq INmune Bio Inc. 2830
INO Nasdaq Inovio Pharmaceuticals, Inc. 2830
INSM Nasdaq Insmed Incorporated 2830
INVA Nasdaq Innoviva, Inc. 2830
IONS Nasdaq Ionis Pharmaceuticals, Inc. 2830
IOVA Nasdaq Iovance Biotherapeutics, Inc. 2830
IPHA Nasdaq Innate Pharma S.A. 2830
IPSC Nasdaq Century Therapeutics, Inc. 2830
IQV New York IQVIA Holdings Inc. 2830
IRD Nasdaq Opus Genetics, Inc. 2830
IVA Nasdaq Inventiva S.A. 2830
Results 100 through 150 of 289